Electricity will remain epileptic until Nigeria embraces nuclear energy – Prof. Inyang

Electricity will remain epileptic until Nigeria embraces nuclear energy – Prof. Inyang

As the author of the STI 2017–2030 roadmap, how far has Nigeria gone in achieving its objectives?

The roadmap itself was well-received at inception. It was approved unanimously by the Federal Executive Council, which signalled strong political endorsement. It was also accompanied by a clear budgetary framework that was meant to guide implementation. However, the gap between approval and execution has been significant. In practical terms, very little has been achieved. The implementation momentum was lost early, largely due to instability in leadership within the supervising ministry. Frequent changes disrupted continuity. Policies of this scale require institutional memory and sustained technical direction. That has been missing.

If I am to quantify progress, I would say Nigeria has achieved no more than about 10 percent of what is required. That is a very low figure for a sector that is central to national development. Science and technology, next only to education, determine productivity levels, economic output and long-term competitiveness. When you compare Nigeria to peer countries on the continent, the picture becomes clearer. Countries such as South Africa, Egypt, Morocco, Algeria and Kenya have moved ahead. They have translated policy into industrial and technological gains. Nigeria, despite its population size, has not done the same. The key metric here is not aggregate GDP, but GDP per capita. Without strengthening science and technology, productivity remains low, and per capita output suffers. That is where Nigeria is lagging.

You recommended biotechnology adoption in the roadmap, particularly for pharmaceuticals. How do you respond to concerns about its safety?

The resistance to biotechnology is understandable but often not grounded in a full appreciation of the realities we face globally. Population growth continues to outpace food production in many regions. Even where production is adequate, distribution remains uneven. It is no longer sufficient to rely solely on natural systems. Human innovation must complement nature. Biotechnology is one of the tools that allows us to do that. It enables the development of crops that can survive drought, poor soils and extreme climates. This is critical for regions like the Sahel and other marginal environments. Opposition tends to generalise. That is not how science works. Each product, whether a crop or a pharmaceutical, must be evaluated individually. If evidence shows that a product is harmful, it should be withdrawn. But it is not scientifically sound to reject an entire field based on isolated concerns.

Biotechnology has already delivered major benefits beyond agriculture. It is used in medicine, prosthetics and emerging therapies. The question should not be whether to adopt it, but how to regulate it responsibly.

There have been claims that some genetically modified crops are carcinogenic. Does this not justify caution?

Caution is always necessary in science, but it must be evidence-based. I have served in advisory roles within the United States, including on environmental policy and technology. These debates are not new. No responsible system should allow carcinogenic products into circulation. That applies across all sectors, not just biotechnology. There are industrial materials that pose health risks, yet they are regulated rather than banned wholesale. The correct approach is case-by-case evaluation. Each crop, each product, must undergo rigorous testing. If it fails, it is removed. If it passes, it is allowed under controlled conditions. Blanket rejection undermines innovation and denies society potential benefits.

You stated that Nigeria’s electricity challenges will persist without nuclear energy. Why do you hold this view?

Nigeria’s energy deficit is structural. Current generation methods have not delivered stable, large-scale power. Hydropower is limited by climate variability. Thermal generation is constrained by infrastructure inefficiencies and gas supply challenges. Nuclear energy offers a high-capacity, stable baseload option. It is not subject to the same fluctuations as renewable sources. Countries that have achieved reliable electricity at scale often include nuclear in their energy mix. However, nuclear energy is not without risks. It requires strong regulatory frameworks, technical expertise and safety culture. It is not something to approach casually. But avoiding it entirely may limit Nigeria’s long-term energy security.

How has the STI roadmap addressed climate change challenges?

Climate change is already affecting Nigeria. The impacts are visible across regions. In the north, desertification is advancing southwards. This affects grazing patterns and contributes to resource conflicts. In the Niger Delta, coastal erosion and changing rainfall patterns are disrupting livelihoods. The roadmap recognised these risks. It emphasised both mitigation and adaptation. Mitigation focuses on reducing emissions and preventing further damage. Adaptation addresses the impacts that are already occurring. Nigeria needs to invest in both. Engineering solutions, policy reforms and economic strategies must work together. Ignoring either side creates vulnerability.

What role does geoengineering play in this context?

Geoengineering is a broad concept. It includes interventions such as carbon capture and storage, as well as modifications to environmental systems to manage climate effects. Its application depends on the sector. In environmental management, it may involve capturing carbon dioxide and storing it in geological formations. In agriculture, it can include soil and crop interventions. Public concern is natural because these interventions affect fundamental systems. But all engineering carries risk. The issue is not risk elimination, which is impossible, but risk management.

What is your assessment of Nigeria’s current performance in science and technology?